2024-06-16
CNBC
13 related
Tempus AI's shares closed up 8.8% at $40.25 in the company's Nasdaq debut, giving it a market value of about $6.6B, after raising $410.7M in its IPO
His Fourth IPO Alex Wilhelm / Cautious Optimism : Tempus goes public as corporate leaders struggle with AI deployments LinkedIn: Scott Gottlieb : Congratulations to the people of #TempusAI for another...
2024-04-24
Bloomberg
6 related
Xaira Therapeutics, which aims to use AI models to find new drugs to treat diseases, emerged from stealth with $1B in commitments from Sequoia and others
read it only @endpts: https://endpts.com/... LinkedIn: Xaira Therapeutics : Incubated by ARCH Venture Partners and Foresite Labs, Xaira Therapeutics is on a mission to drive advances in artificial int...
2018-06-03
BuzzFeed
A look at how social networks are being used to illegally sell prescription medications despite Terms of Service that forbid the practice
Every social media website reviewed by BuzzFeed News was host to dealers of opioids and other prescription medicine. Tweets: @janelytv , @aimee2day , and @sgottliebfda Tweets: @janelytv : New from me:...
Loading articles...